India can be a big provider of genomics big data analytics, says government official

21 September 2015

India can emerge as a key provider of high-end analytics based on genomics big data, stated Vijay Raghavan, Secretary, Department of Biotechnology, Ministry of Science & Technology, Government of India, at an interactive session on biotechnology on day two of the ‘Indian Economic Convention’ organized by India Foundation and International Chamber of Commerce, whose India Chapter is an affiliate body of the Federation of Indian Chambers of Commerce and Industry (FICCI), in association with Niti Aayog.

There is a big opportunity for India to both analyze and model genomics big data and to build mechanisms for using the analytics, said Mr Raghavan, and pointed out that India should also look to build a sizeable pool of people who are trained to handle computational genomics.

Deeper need for interaction stressed

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Biotechnology